|
MMWR Publications |
|
|
|
MMWR Information |
|
|
|
Additional Resources |
|
|
|
|
|
Updated
|
|
|
|
This Week in MMWR
|
July
3, 2009 / Vol. 58 / No. 25
|
|
|
|
|
Photo/CDC
Since 2006, hepatitis A vaccination has been recommended for all U.S. children aged 12-23 months.
|
|
Hepatitis A Vaccination Coverage Among Children Aged 24-35 Months
United States, 2006 and 2007
In 2006, the Advisory Committee on Immunization Practices (ACIP) expanded its hepatitis A vaccination recommendation to all children in the United States and reduced the recommended age for vaccination to 12-23 months. This report updates previous findings regarding hepatitis A vaccination coverage, providing estimates based on National Immunization Survey (NIS) data. From 2006 to 2007, national hepatitis A vaccination coverage levels among children aged 24-35 months who received at least 1 dose increased from 26.3% to 47.4%.
|
|
MORE REPORTS
|
DOWNLOAD ISSUE
|
|
|
MMWR Recommendations and Reports
June 12, 2009 / Vol. 58 / No. RR–6
Good Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Conditions
Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations, laboratory testing is categorized as waived (from routine regulatory oversight) or nonwaived based on the complexity of the tests; tests of moderate and high complexity are nonwaived tests. Laboratories that perform molecular genetic testing are subject to the general CLIA quality systems requirements for nonwaived testing and the CLIA personnel requirements for tests of high complexity. This report provides recommendations from the Clinical Laboratory Improvement Advisory Committee for good laboratory practices for ensuring the quality of molecular genetic testing for heritable diseases and conditions. Improvements in the quality and use of genetic laboratory services should improve the quality of health care and health outcomes for patients and families of patients.
|
|
DOWNLOAD ISSUE
|
|
|
MMWR Surveillance Summaries
June 12, 2009 /
Vol. 58 / No. SS–5
Assisted Reproductive Technology Surveillance
United States, 2006
Assisted Reproductive Technology (ART)
procedures are used to overcome
infertility. It includes infertility
treatments in which eggs and sperm are
handled in the laboratory to establish a
pregnancy. Women who undergo those
procedures are more likely to deliver
multiple-birth infants than those who
conceive naturally. This report presents
the most recent national data and
state-specific results.
|
|
DOWNLOAD
ISSUE
|

|
|
|
|
|
|
|
|
|
|
|
Subscribe
to MMWRTo receive an
electronic subscription to the MMWR Series, please enter
your e-mail address:
MMWR
Podcasts
Hib Booster is Back
A Minute of Health with CDC
Listen (Length: 0:59)
View transcript
A Cup of Health with CDC
Listen (Length: 3:58)
View transcript
MMWR
RSS Feed
How to Add MMWR RSS feeds
Learn More About RSS
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT IMMUNIZATION
SCHEDULES |
|
January 2, 2009, Vol. 57, No. 51 & 52
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years ---
United States, 2009
The Advisory Committee on Immunization
Practices (ACIP) annually publishes a recommended immunization
schedule for persons aged 0--18 years to reflect changes in
vaccine formulations and current recommendations for the use of
licensed vaccines.
DOWNLOAD
ISSUE
January 9, 2009, Vol. 57, No. 53
Recommended Adult Immunization Schedule --- United States, 2009
The Advisory Committee on Immunization
Practices (ACIP) annually reviews the recommended Adult
Immunization Schedule to ensure that the schedule reflects
current recommendations for the licensed vaccines. In June
2007, ACIP approved the Adult Immunization Schedule for
October 2007--September 2008.
DOWNLOAD
ISSUE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|